Literature DB >> 36098874

Checking Out the Associations Between Inflammatory Bowel Disease and Checkpoint Inhibitor Colitis.

Tenzin Choden1, Mia Yeager2, Russell D Cohen3,4.   

Abstract

Entities:  

Year:  2022        PMID： 36098874     DOI： 10.1007/s10620-022-07668-5

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.487


× No keyword cloud information.
  11 in total

1.  Molecular Pathways of Colon Inflammation Induced by Cancer Immunotherapy.

Authors:  Adrienne M Luoma; Shengbao Suo; Hannah L Williams; Tatyana Sharova; Keri Sullivan; Michael Manos; Peter Bowling; F Stephen Hodi; Osama Rahma; Ryan J Sullivan; Genevieve M Boland; Jonathan A Nowak; Stephanie K Dougan; Michael Dougan; Guo-Cheng Yuan; Kai W Wucherpfennig
Journal:  Cell       Date:  2020-06-29       Impact factor: 41.582

Review 2.  Checkpoint Inhibitor-Induced Colitis.

Authors:  Emanuelle Bellaguarda; Stephen Hanauer
Journal:  Am J Gastroenterol       Date:  2020-02       Impact factor: 10.864

3.  AGA Clinical Practice Update on Diagnosis and Management of Immune Checkpoint Inhibitor Colitis and Hepatitis: Expert Review.

Authors:  Michael Dougan; Yinghong Wang; Alberto Rubio-Tapia; Joseph K Lim
Journal:  Gastroenterology       Date:  2020-10-17       Impact factor: 22.682

4.  Can Immune Checkpoint Inhibitors Induce Microscopic Colitis or a Brand New Entity?

Authors:  Kati Choi; Hamzah Abu-Sbeih; Rashmi Samdani; Graciela Nogueras Gonzalez; Gottumukkala Subba Raju; David M Richards; Jianjun Gao; Sumit Subudhi; John Stroehlein; Yinghong Wang
Journal:  Inflamm Bowel Dis       Date:  2019-01-10       Impact factor: 5.325

5.  Endoscopic and Histologic Features of Immune Checkpoint Inhibitor-Related Colitis.

Authors:  Yinghong Wang; Hamzah Abu-Sbeih; Emily Mao; Noman Ali; Wei Qiao; Van Anh Trinh; Chrystia Zobniw; Daniel Hartman Johnson; Rashmi Samdani; Phillip Lum; Gladis Shuttlesworth; Boris Blechacz; Robert Bresalier; Ethan Miller; Selvi Thirumurthi; David Richards; Gottumukkala Raju; John Stroehlein; Adi Diab
Journal:  Inflamm Bowel Dis       Date:  2018-07-12       Impact factor: 5.325

6.  Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update.

Authors:  Bryan J Schneider; Jarushka Naidoo; Bianca D Santomasso; Christina Lacchetti; Sherry Adkins; Milan Anadkat; Michael B Atkins; Kelly J Brassil; Jeffrey M Caterino; Ian Chau; Marianne J Davies; Marc S Ernstoff; Leslie Fecher; Monalisa Ghosh; Ishmael Jaiyesimi; Jennifer S Mammen; Aung Naing; Loretta J Nastoupil; Tanyanika Phillips; Laura D Porter; Cristina A Reichner; Carole Seigel; Jung-Min Song; Alexander Spira; Maria Suarez-Almazor; Umang Swami; John A Thompson; Praveen Vikas; Yinghong Wang; Jeffrey S Weber; Pauline Funchain; Kathryn Bollin
Journal:  J Clin Oncol       Date:  2021-11-01       Impact factor: 44.544

7.  Late-Onset Inflammatory Bowel Disease-Like Syndrome after Ipilimumab Therapy: A Case Report.

Authors:  Reem Akel; Bilal Anouti; Arafat Tfayli
Journal:  Case Rep Oncol       Date:  2017-05-23

8.  Resumption of Immune Checkpoint Inhibitor Therapy After Immune-Mediated Colitis.

Authors:  Hamzah Abu-Sbeih; Faisal S Ali; Abdul Rafeh Naqash; Dwight H Owen; Sandipkumar Patel; Gregory A Otterson; Kari Kendra; Biagio Ricciuti; Rita Chiari; Andrea De Giglio; Joseph Sleiman; Pauline Funchain; Beatriz Wills; Jiajia Zhang; Jarushka Naidoo; Jessica Philpott; Jianjun Gao; Sumit K Subudhi; Yinghong Wang
Journal:  J Clin Oncol       Date:  2019-06-04       Impact factor: 44.544

9.  Immune Checkpoint Inhibitor Therapy in Patients With Preexisting Inflammatory Bowel Disease.

Authors:  Hamzah Abu-Sbeih; David M Faleck; Biagio Ricciuti; Robin B Mendelsohn; Abdul R Naqash; Justine V Cohen; Maclean C Sellers; Aanika Balaji; Guy Ben-Betzalel; Ibraheim Hajir; Jiajia Zhang; Mark M Awad; Giulia C Leonardi; Douglas B Johnson; David J Pinato; Dwight H Owen; Sarah A Weiss; Giuseppe Lamberti; Mark P Lythgoe; Lisa Manuzzi; Christina Arnold; Wei Qiao; Jarushka Naidoo; Gal Markel; Nick Powell; Sai-Ching J Yeung; Elad Sharon; Michael Dougan; Yinghong Wang
Journal:  J Clin Oncol       Date:  2019-12-04       Impact factor: 44.544

10.  Importance of endoscopic and histological evaluation in the management of immune checkpoint inhibitor-induced colitis.

Authors:  Hamzah Abu-Sbeih; Faisal S Ali; Wenyi Luo; Wei Qiao; Gottumukkala S Raju; Yinghong Wang
Journal:  J Immunother Cancer       Date:  2018-09-25       Impact factor: 13.751
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.